Top Biotechnology companies in Norway by Revenue

This ranking features the top 16 Biotechnology companies in Norway ranked by Revenue, totalling a Revenue of USD 1.47 B, for January 15, 2025.
#
Name
Revenue
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 689.58 M
Dec. 31, 2023 USD 15.98 -1.62%

Norway

2
USD 335.30 M
Dec. 31, 2023 USD 5.71 2.33%

Norway

3
USD 335.27 M
Dec. 31, 2023 USD 5.88 -1.04%

Norway

4
USD 26.45 M
Dec. 31, 2023 USD 1.21 2.68%

Norway

5
USD 19.13 M
Dec. 31, 2023 USD 0.17 -2.50%

Norway

6
USD 15.05 M
Dec. 31, 2023 USD 0.57 1.53%

Norway

7
USD 13.37 M
Dec. 31, 2023 USD 3.46 4.14%

Norway

8
USD 12.90 M
Dec. 31, 2023 USD 0.23 0.44%

Norway

9
USD 11.68 M
Dec. 31, 2023 USD 1.20 -0.29%

Norway

10
USD 3.66 M
Dec. 31, 2023 USD 3.42 0.44%

Norway

11
USD 3.38 M
Dec. 31, 2023 USD 0.54 -0.84%

Norway

12
USD 1.28 M
Dec. 31, 2023 USD 1.36 33.77%

Norway

13
USD 293.54 K
Dec. 31, 2023 USD 0.11 -3.45%

Norway

14
USD 34.75 K
Dec. 31, 2023 USD 0.77 -0.80%

Norway

15
USD 0.00
Dec. 31, 2023 USD 0.22 4.62%

Norway

16
USD 0.00
Dec. 31, 2023 USD 0.19 2.37%

Norway

Frequently Asked Questions
  • Which Biotechnology company in Norway has the highest Revenue ?

    The Biotechnology company in Norway with the highest Revenue is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 689.58 M.

  • Which Biotechnology company in Norway has the lowest Revenue ?

    The Biotechnology company in Norway with the lowest Revenue is Ultimovacs ASA (Oslo Stock Exchange: ULTI.OL) at USD 0.00.